الفهرس 
Types And Histopathologicla Backgroud Of Bone TumorsOnly 14 pages are availabe for public view
 |  | from | 178 |  |  |
| | | from | 178 | | |
Abstract
Introduction: Bone tumors include a variety of lesions, both primary and metastatic. The treatment modalities for bone tumors vary with the individual lesion, but in general surgical excision is the treatment of choice with other adjunctive therapies. However, surgery for many bone tumors is complex due to several factors including tu¬mor bulk, vascularity, vicinity to vital structures and potentially inaccessible location of the lesion. Transarte¬rial Embolisation (TAE) is one of the important adjuvant treatment modalities and in some cases it may be the primary and curative treatment.
Objectives: To highlight the value of preoperative embolization of vascular bone tumors to reduce operative and postoperative blood loss and also its role as a primary and curative therapy.
Data Sources: Medline databases (PubMed, Medscape, ScienceDirect. EMF-Portal) and all materials available in the Internet till 2018.
Study selection: This search presented 113 articles. The articles studied the role of preoperative embolization of vascular bone tumors.
Data Extraction: If the studies did not fulfill the inclusion criteria, they were excluded. Study quality assessment included whether ethical approval was gained, eligibility criteria specified, appropriate controls, and adequate information and defined assessment measures.
Data Synthesis: Comparisons were made by structured review with the results tabulated.
Conclusions: Preoperative TAE has proved to be effective in both primary and metastatic bone tumors. It reduces tumor vascularity and intra-operative blood loss, the need for blood transfusion and associated complications, allows better definition of tissue planes at surgery affording more complete excision, and hence reduced recurrence.